A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Researchers from the People's Friendship University of Russia (RUDN University) have studied the mechanism of drug resistance for ovarian and breast cancer cells. They discovered that these cancer ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...